Jeffrey Greenspoon
Papers
3
Total Citations
76
H-Index
3
About
Jeffrey Greenspoon is a radiation oncologist whose research focuses on advanced stereotactic radiosurgery and radiotherapy techniques for challenging cancers, particularly glioblastoma multiforme and prostate cancer. His most impactful work, a prospective cohort study on fractionated stereotactic radiosurgery combined with temozolomide chemotherapy for locally recurrent glioblastoma (56 citations), demonstrated significant response rates and acceptable toxicity, offering a crucial salvage option for a disease with limited treatments. This contribution addresses a critical gap in managing aggressive brain tumors. Greenspoon has also advanced the field of stereotactic body radiotherapy (SBRT) for prostate cancer, detailing the techniques, resources, and costs associated with robotic and arc-based systems. His research extends to health economics, as seen in his pragmatic cost-benefit analysis of robotic radiosurgery for brain metastases, incorporating willingness-to-pay metrics to guide resource allocation. Through these studies, Greenspoon has helped refine treatment protocols, improve patient outcomes, and inform the efficient deployment of costly radiotherapy technologies, making him a key figure in modern radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3